SAVE THE DATES & REGISTRATION

Hosted by The Global HIV Vaccine Enterprise in partnership with the HIV Vaccine Trials Network, the HIV Prevention Trials Network and and the Forum for Collaborative Research

Registration for Session 3B (27 April 2021) now open !

IF YOU HAVE ALREADY ATTENDED TO A PREVIOUS SESSION YOU DO NOT NEED TO REGISTER AGAIN,

YOU WILL RECEIVE THE ZOOM REGISTRATION BY EMAIL.

If you are attending for the first time, please register below to get your personal Zoom link on the next page!

HIV prevention is evolving rapidly with the roll out of new tools such as pre-exposure prophylaxis (PrEP) and treatment as prevention making a significant contribution towards controlling the epidemic. As a result, the design and conduct of the next generation of prevention trials is impacted and is further affected by the outcomes of ongoing HIV prevention efficacy trials – including oral and injectable antiretrovirals, passively infused monoclonal antibodies, and HIV vaccines.

This series of virtual workshop aims to continue from the first HIV Prevention Efficacy Trial Designs of the Future symposium, held in November 2018 in Seattle by the Fred Hutch and the NIAID, which led to a series of articles published in Statistical Communications in Infectious Diseases and a viewpoint in The Lancet HIV.

Participants will reflect on more recent advances and challenges within the HIV prevention field and on the rationale and lessons learned for current HIV prevention designs. They will examine novel scientific approaches for establishing efficacy of new biologics in a future where all trial participants have access to effective prevention.

The event will feature a series of online talks given by biostatisticians and clinical trial experts, and will include live panel discussions with clinicians, ethicists, regulators, community members and sponsors.

The programme is designed to accommodate virtual interactions and will offer pre-recorded presentations available online on-demand and live events focused on discussion.

A series of articles, based on the talks given at the symposium, will be published in a selected high-impact journal.

Please share among your network.

More details on each session will be sent out closer to the date.

Organizing Committee

• Holly Prudden, International AIDS Society, Geneva, Switzerland.
• Holly Janes, Fred Hutchinson Cancer Research Center, Seattle, USA.
• Deborah Donnell, Fred Hutchinson Cancer Research Center, Seattle, USA.
• Stephaun Wallace, Fred Hutchinson Cancer Research Center, Seattle, USA.
• Veronica Miller, Forum for Collaborative Research, Berkeley, USA.
• Roger Tatoud, International AIDS Society, Geneva, Switzerland.
• Linda-Gail Bekker. Desmond Tutu HIV Centre, University of Cape Town (UCT), South Africa.

For queries, please contact enterprise@iasociety.org.

The organization of this workshop is supported by a grant from the Bill and Melinda Gates Foundation and the US National Institutes of Health (NIH).